LONDON (Reuters) – The failure by drugmakers and researchers to publish results from all clinical trials – whether good or bad – is risking patient safety, British lawmakers said on Tuesday in a report that adds to pressure for more transparency.
LONDON (Reuters) – The failure by drugmakers and researchers to publish results from all clinical trials – whether good or bad – is risking patient safety, British lawmakers said on Tuesday in a report that adds to pressure for more transparency.
